Interestingly, patients assigned to the category “rapid increase and slow decrease with higher persistence” seemed to have the best response rate, but also a higher risk of CRS, independently from the IL-6 gene expression [147] (Table 3). The gene discussed is IL6; the disease is congenital rubella syndrome.